← Eichor
Study identifier: NCT06096688 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Discovering New Targets for Colorectal and Endometrial Cancer Risk Reduction

Condition: Colorectal Cancer · Endometrial Cancer · Hereditary Cancer Syndromes  ·  Sponsor: Weill Medical College of Cornell University

PhaseN/A
Planned participants1120
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersYes

About this study

The primary aim of this study is to collect and store data, tissue, and personal and family histories from patients being screened for colorectal cancer and/or endometrial cancer at NYPH and WCM for routine clinical care and to make these available for future use for molecular and mechanistic studies.

This description comes directly from the study's public registry record.

Talk to the study team

Steven M Lipkin, MD, PhD  ·  212-746-4014  ·  stl2012@med.cornell.edu

Melissa K Frey, MD, MS  ·  646-697-6621  ·  mkf2002@med.cornell.edu

Always discuss trial participation with your own doctor first.

Locations (1)

NYP/Weill Cornell MedicineNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06096688